Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma

Part of paid clinical trials in Gilbert, Arizona.

Sponsor
Bristol-Myers Squibb
Study ID
NCT02186249
Status
No Longer Available

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to provide treatment with nivolumab in combination with ipilimumab to subjects who are anti-(CTLA)-4 and anti-PD-1 treatment-naive and have unresectable or metastatic melanoma.

Key Dates

Status verified
Feb 2017

Locations (57)

FacilityCityStateZIPSite coordinators
Banner MD Anderson Cancer CenterGilbertArizona85234-
Mayo Clinic ArizonaPhoenixArizona85054-
6501 Truxtun AvenueBakersfieldCalifornia93309-
UC San Diego Moores Cancer CenterLa JollaCalifornia92093-
100 UCLA Medical PlazaLos AngelesCalifornia90095-
514 North Prospect AveRedondo BeachCalifornia90277-
California Pacific Medical Center Research InstituteSan FranciscoCalifornia94115-
University of California San FranciscoSan FranciscoCalifornia94115-
1325 East Church StreetSanta MonicaCalifornia93454-
Angeles Clinic and Research InstituteSanta MonicaCalifornia90404-
University of Colorado HospitalAuroraColorado80045-
Rocky Mountain Cancer CentersLittletonColorado80120-
Smilow Cancer Hospital at Yale University Cancer CenterNew HavenConnecticut06519-
Georgetown-Lombardi Comprehensive Cancer CenterWashington D.C.District of Columbia20007-
Memorial Regional HospitalHollywoodFlorida33021-
4500 San Pablo Road SouthJacksonvilleFlorida32224-
Cancer Specialists of North FloridaJacksonvilleFlorida32256-
UF Health Cancer Center at Orlando HealthLongwoodFlorida32750-
Mount Sinai Medical CenterMiami BeachFlorida33140-
Florida Hospital Cancer InstituteOrlandoFlorida32804-
H. Lee Moffitt Cancer Center & Research InstituteTampaFlorida33612-
Winship Cancer InstituteAtlantaGeorgia30322-
600 Celebrate Life ParkwayNewnanGeorgia30265-
Evanston Premier Healthcare Research LLCEvanstonIllinois60201-
Oncology Specialists, SCNilesIllinois60714-
Local InstitutionLouisvilleKentucky40202-
Johns Hopkins Sidney Kimmel Comprehensive Cancer CenterBaltimoreMaryland21231-
Medstar Health Research InstituteBaltimoreMaryland21204-
Center For Cancer and Blood DisordersBethesdaMaryland20817-
Beth Israel Deaconess Medical CenterBostonMassachusetts02215-
Dana Farber Cancer InstituteBostonMassachusetts02215-
Massachusetts General HospitalBostonMassachusetts02214-
University of Michigan Comprehensive Cancer CenterAnn ArborMichigan48109-
Karmanos Cancer InstituteDetroitMichigan48201-
Cancer and Hematology Centers of Western MichiganGrand RapidsMichigan49503-
Mayo ClinicRochesterMinnesota55905-
Washington University School of MedicineSt LouisMissouri63110-
Comprehensive Cancer Centers of NevadaLas VegasNevada89148-
Atlantic Health SystemMorristownNew Jersey07960-1089-
Memorial Sloan-Kettering Cancer CenterNew YorkNew York10017-
NYU Langone Medical CenterNew YorkNew York10016-
Carolinas Healthcare SystemCharlotteNorth Carolina28204-
Tulsa Cancer Institute PLLCTulsaOklahoma74146-
Northwest Cancer Specialists PCPortlandOregon97213-
Lehigh Valley Health NetworkAllentownPennsylvania18103-
St Luke's HospitalBethlehemPennsylvania18015-
Greenville Health SystemEasleySouth Carolina29640-
Tennessee Oncology PLLCNashvilleTennessee37203-
Texas OncologyAustinTexas78731-
MD Anderson Cancer CenterHoustonTexas77030-
Texas OncologyMidlandTexas79701-
Texas OncologyParisTexas75460-
Virginia Cancer InstituteRichmondVirginia23230-
Oncology and Hematology Associates of Southwest Virginia, IncRoanokeVirginia24014-
Shenandoah Oncology AssociationWinchesterVirginia22601-
Seattle Cancer Care AllianceSeattleWashington98109-
University of WisconsinMadisonWisconsin53792-

Find similar trials in Gilbert, AZ

By condition

Related Studies